Regorafenib as Salvage Treatment in Korean Patients with Refractory Metastatic Colorectal Cancer

PURPOSE: Regorafenib, an oral multi-targeted tyrosine kinase inhibitor, is considered the new standard of care in patients with chemotherapy-refractory colorectal cancers (CRCs). However, there are no data on this drug in Korean patients. MATERIALS AND METHODS: We evaluated patients who received ora...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Res Treat
Hauptverfasser: Kim, Seung Tae, Kim, Tae Won, Kim, Kyu-pyo, Kim, Tae-You, Han, Sae-Won, Lee, Ji Yun, Lim, Sung Hee, Lee, Min-Young, Kim, Haesu, Park, Young Suk
Format: Artigo
Sprache:Inglês
Veröffentlicht: Korean Cancer Association 2015
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4614225/
https://ncbi.nlm.nih.gov/pubmed/25672574
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2014.126
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge